Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Identifying biomarkers for aortic aneurysm and dissection

Official title: Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen

Run by Beijing Institute of Heart, Lung and Blood Vessel Diseases · NCT03233087 · Data updated 2026-11-12

This study is trying to find specific markers in the blood that can help doctors diagnose and predict outcomes for people with aortic aneurysm and aortic dissection.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment1500 (estimated)
SponsorBeijing Institute of Heart, Lung and Blood Vessel Diseases
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMarch 1, 2014
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedJune 27, 2024
Trial IDNCT03233087 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients referred for evaluation of aortic dissection or those with suspected aortic aneurysm or dissection.

Probably not a fit

Patients with conditions unrelated to aortic dissection or those with significant comorbidities like active cancer or severe pulmonary diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the role of specific biomarkers in diagnosing and predicting outcomes for patients with aortic aneurysm (AA) and aortic dissection (AD). It includes a discovery phase with a matched case-control design, where patients with various outcomes are compared to healthy controls. The prognosis aspect focuses on patients with confirmed AA and AD, tracking all-cause mortality and in-hospital mortality through medical records and death certificates. The study aims to enhance understanding of these conditions and improve patient management.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and prognostic tools for patients with aortic aneurysm and dissection.

How similar studies have gone: Other studies have explored biomarkers in cardiovascular conditions, but this specific approach to aortic aneurysm and dissection is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Retrospective

* All patients who were referred to the surgical service for evaluation and management of aortic dissection were included.

Perspective

* Patients with initial suspicion of having AAD were perspectively enrolled.

Exclusion Criteria:

Retrospective

* Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken;
* Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer;
* Patients who entered the hospital for checkups after surgery.

Perspective

* Patients in whom there is little or no suspicion of a life-threatening disease;
* Patients with confirmed acute myocardial infarction,angina or pulmonary embolism
* The symptoms were clearly not related to AD (e.g. pleurisy, pneumonia, acute abdominal diseases).

Where it's running

  • Beijing Anzhen Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Improving brain protection during aortic arch surgery

    This study is testing a new way to monitor brain health during aortic arch surgery to see if it can help prevent brain problems after the operation.

    Recruiting Barts & The London NHS Trust · London · NCT04966247

  • Evaluation of the NEXUS Aortic Arch Stent Graft System for treating aortic conditions

    This study is testing a new stent graft system to see if it can safely and effectively treat certain aortic problems in patients with specific conditions.

    Recruiting at 25 sites Endospan Ltd. · Birmingham, Alabama and 31 other locations · NCT04471909

  • Precision medicine for heritable thoracic aortic disease

    This study is trying to learn more about genetic factors in people with heritable thoracic aortic disease to help doctors better predict risks and manage their care.

    Recruiting at 20 sites The University of Texas Health Science Center, Houston · Newport Beach, California and 19 other locations · NCT04005976

  • Project to improve cardiovascular health through biobanking

    This project is collecting blood samples and health information from people with heart diseases and healthy individuals to help researchers learn more about heart health and its genetic factors.

    Recruiting University of Michigan · Ann Arbor, Michigan · NCT02306200

  • Pregnancy-Related Aortic Dissection in China

    This study looks at cases of aortic dissection that occur during pregnancy or shortly after, to understand outcomes for mothers and babies.

    Recruiting at 4 sites DeltaHealth Hospital · Shanghai · Shanghai, Shanghai Municipality and 3 other locations · NCT07672210

  • Physician-modified endografts for aortic disease in high-risk patients

    This study tests a physician-modified Terumo Treo abdominal stent-graft to see if it can safely treat large aortic aneurysms in patients who are high-risk for open surgery.

    Recruiting Mayo Clinic · Jacksonville, Florida · NCT07611968

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.